Gain Therapeutics Inc.
GANX | NASDAQ
$1.95
+$0.11 (+5.98%)
At close: Sep 22, 2026, 4:00 PM ET
$1.95
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Institutional Ownership
Net InflowTotal Institutions
46
Total Ownership
19.41%
Capital Flow
+$10.11M
Shares Change
+136.68K
Ownership Distribution
Institutions (19.41%)
Others (80.59%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
neutralNew Positions
9
Increased Positions
19
Reduced Positions
10
Closed Positions
16
New (9)
Increased (19)
Reduced (10)
Closed (16)
Options Sentiment & Activity
bullishPut/Call Ratio
0.344
Call Flow
91,400
Put Flow
31,400
Calls (74%)
Puts (26%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Greenlight Capital Inc | 1.39% 0.00% | 0.04% | 588.41K | 1.06M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Marshall Wace, Llp | 4.19% -16.88% | < 0.01% -29.82% | 1.77M +6.47% | 3.43M -35.86% | |
| Potomac Capital Management, Inc. | 2.39% -22.04% | 1.70% -34.86% | 1.01M -0.14% | 1.96M -39.84% | |
| Jones Financial Companies Lllp | 1.50% -29.78% | < 0.01% -59.70% | 631.62K -10.05% | 1.16M -48.88% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove GANX